Trials / Recruiting
RecruitingNCT02917369
Integrative Analysis of Large-cell Lung Cancer
Integrative Analysis of Large-cell Lung Carcinoma
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (estimated)
- Sponsor
- Shanghai 10th People's Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Integrative analysis of LCLC
Detailed description
The investigators will analyzed proteomes of paired normal lung tissues and LCLC with or without liver metastasis, sequenced transcriptomes, perform whole exome sequencing, and single nucleotide polymorphism (SNP) array profiling for triplets, each comprising normal lung tissue, primary LCLC carcinoma, and its synchronous matched metastasis, as well as analyzed genomics of lung cancer characterized previously by The Cancer Genome Atlas (TCGA) to conduct integrated proteogenomic analyses.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Normal lung tissue | The investigators will extract total protein, DNA and RNA from LCLC patients. |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2026-12-01
- Completion
- 2026-12-01
- First posted
- 2016-09-28
- Last updated
- 2016-09-28
Locations
3 sites across 1 country: China
Source: ClinicalTrials.gov record NCT02917369. Inclusion in this directory is not an endorsement.